Below are the financial statements of Axsome Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenues | — | — | — |
| Product sales, net | 381.68a | 202.46a | 50.04a |
| License revenue | 0a | 65.74a | 0a |
| Royalty and milestone revenue | 4.02a | 2.41a | 0a |
| Total revenues | 385.69a | 270.6a | 50.04a |
| Operating expenses | — | — | — |
| Cost of revenue (excluding amortization and depreciation) | -33.3a | -26.07a | -5.2a |
| Research and development | -187.08a | -97.94a | -57.95a |
| Selling, general and administrative | -411.36a | -323.12a | -159.25a |
| Loss in fair value of contingent consideration | -28.12a | -48.92a | -3.3a |
| Intangible asset amortization | -6.39a | -6.38a | -4.14a |
| Total operating expenses | -666.26a | -502.43a | -229.84a |
| Loss from operations | -280.56a | -231.83a | -179.8a |
| Interest expense, net | -6.57a | -6.45a | -7.34a |
| Loss before income taxes | -287.13a | -238.28a | -187.13a |
| Income tax expense | -0.09a | -0.96a | 0a |
| Net loss | -287.22a | -239.24a | -187.13a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Axsome Therapeutics’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.